Caribou Biosciences, Inc. (CRBU)
0.4602
-0.02
(-4.36%)
USD |
NASDAQ |
Oct 09, 16:00
0.48
+0.02
(+4.30%)
After-Hours: 07:25
Caribou Biosciences Free Cash Flow : -95.75M for June 30, 2026
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | -95.75M |
| March 31, 2026 | -101.64M |
| December 31, 2025 | -112.35M |
| September 30, 2025 | -127.73M |
| June 30, 2025 | -135.76M |
| March 31, 2025 | -142.20M |
| December 31, 2024 | -143.08M |
| September 30, 2024 | -130.75M |
| June 30, 2024 | -130.95M |
| March 31, 2024 | -113.58M |
| December 31, 2023 | -104.90M |
| September 30, 2023 | -108.05M |
| Date | Value |
|---|---|
| June 30, 2023 | -98.24M |
| March 31, 2023 | -104.99M |
| December 31, 2022 | -97.42M |
| September 30, 2022 | -92.69M |
| June 30, 2022 | -84.86M |
| March 31, 2022 | -77.33M |
| December 31, 2021 | -34.64M |
| September 30, 2021 | -20.67M |
| June 30, 2021 | -13.48M |
| March 31, 2021 | -3.775M |
| December 31, 2020 | -33.53M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Intellia Therapeutics, Inc. | -348.69M |
| Vir Biotechnology, Inc. | -203.59M |
| Arrowhead Pharmaceuticals, Inc. | -75.11M |
| Oncolytics Biotech, Inc. | -26.53M |
| Sangamo Therapeutics, Inc. | -90.46M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -22.79M |
| Cash from Investing (Quarterly) | 18.94M |
| Cash from Financing (Quarterly) | 17.94M |
| Free Cash Flow Per Share (Quarterly) | -0.2257 |
| Free Cash Flow to Equity (Quarterly) | -22.50M |
| Free Cash Flow to Firm (Quarterly) | -22.79M |
| Free Cash Flow Yield | -216.4% |